ChromaAccess.Ai™ is an AI-powered multiomic integration platform designed to decode chromatin accessibility with high resolution. It combines raw genomic sequences with epigenomic signatures like chromatin openness (ATAC-seq) and DNA methylation to infer functional regulatory regions across the genome. This integrated view provides deeper insight into how non-coding regions influence gene expression, helping to connect genetic variants to disease mechanisms and therapeutic opportunities.
ChromaAccess.Ai™ transforms fragmented epigenomic signals into actionable insight by integrating genomic, ATAC-seq, and methylation data to reconstruct high-resolution regulatory landscapes. It assigns functional relevance to non-coding variants, accelerates biomarker discovery, and uncovers the epigenetic mechanisms underlying disease.
By bridging experimental gaps and revealing how chromatin accessibility influences gene expression and phenotype, the platform empowers researchers to make more informed, mechanistically driven decisions in diagnostics, stratification, and therapeutic development.
ChromaAccess.Ai™ is designed to seamlessly integrate into research workflows by combining genomic, ATAC-seq, and DNA methylation data. Using machine learning models trained on multiomic datasets, the platform predicts chromatin accessibility with high precision, enabling accurate mapping of active regulatory regions. This integrated approach bridges the gaps left by isolated experimental methods and generates functional insights into gene regulation, disease mechanisms, and epigenetic variation.
Combines ATAC-seq, methylation, and genomic data to deliver a comprehensive view of chromatin accessibility and regulatory landscapes.
Predicts chromatin accessibility across the genome with precision, even in regions lacking direct experimental data.
Assigns biological meaning to regulatory mutations, enabling better understanding of their role in disease.
Reveals how chromatin states influence transcriptional activity, aiding in hypothesis generation and validation.
Identifies regulatory elements and accessibility signatures correlated with disease, supporting novel biomarker and therapeutic target identification.
Delivers intuitive, scalable insights suited for both research and clinical applications, with outputs designed for downstream integration and reporting.
Would you like us to get in touch with you? Fill up the form & we will reach out to you